These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6649535)

  • 1. [Dihydropteridine reductase activity in leukocytes and cultured fibroblasts of health individuals and of patients with the classical form of phenylketonuria].
    Gromov PS; Val'iano NM; Akhunov VS; Annenkov GA
    Vopr Med Khim; 1983; 29(5):66-9. PubMed ID: 6649535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydropteridine reductase deficiency: diagnosis by leukocyte enzyme assay.
    Narisawa K; Arai N; Ishizawa S; Ogasawara Y; Onuma A; Iinuma K; Tada K
    Clin Chim Acta; 1980 Aug; 105(3):335-42. PubMed ID: 7408193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atypical phenylketonuria with normal dihydropteridine reductase activity.
    Rey F; Blandin-Savoja F; Rey J
    N Engl J Med; 1976 Nov; 295(20):1138-9. PubMed ID: 980015
    [No Abstract]   [Full Text] [Related]  

  • 4. Phenylalanine has no effect on dihydropteridine reductase activity in phenylketonuria fibroblasts.
    Guttler F; Kaufman S; Milstien S
    Lancet; 1977 Nov; 2(8048):1139-40. PubMed ID: 73054
    [No Abstract]   [Full Text] [Related]  

  • 5. Phenylketonuria due to a deficiency of dihydropteridine reductase.
    Kaufman S; Holtzman NA; Milstien S; Butler LJ; Krumholz A
    N Engl J Med; 1975 Oct; 293(16):785-90. PubMed ID: 1160969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydropteridine-reductase activity in breast cancer. Preliminary report.
    Dhondt JL; Bonneterre J; Farriaux JP; Lefebvre J; Demaille A
    Biomedicine; 1981 May; 35(2):58-60. PubMed ID: 6266525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical phenylketonuria with normal phenylalanine hydroxylase and dihydropteridine reductase activity in vitro.
    Bartholomé K; Byrd DJ; Kaufman S; Milstien S
    Pediatrics; 1977 May; 59(5):757-61. PubMed ID: 300866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and properties of NADH-specific dihydropteridine reductase from human erythrocytes.
    Nakanishi N; Yoshida A; Ozawa K; Yamada S
    Enzyme; 1986; 35(1):42-52. PubMed ID: 3732224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperphenylalaninemia due to dihydropteridine reductase deficiency. Assay of the enzyme in fibroblasts from affected infants, heterozygotes, and in normal amniotic fluid cells.
    Milstien S; Holtzman NA; O'Flynn ME; Thomas GH; Butler IJ; Kaufman S
    J Pediatr; 1976 Nov; 89(5):763-6. PubMed ID: 978323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comparative effects of different inhibitors of phenylalanine hydroxylase and dihydropteridine reductase. In vivo and in vitro study in rats].
    Charpentier C; Domange C; Wolf M; Barthon F; Laggoune B; Lemonnier A
    Arch Fr Pediatr; 1978 Dec; 35(10 Suppl):93-101. PubMed ID: 571268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperphenylalaninemia due to dihydropteridine reductase deficiency: diagnosis by enzyme assays on dried blood spots.
    Arai N; Narisawa K; Hayakawa H; Tada K
    Pediatrics; 1982 Sep; 70(3):426-30. PubMed ID: 7110817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NADH-ferric reductase activity associated with dihydropteridine reductase.
    Lee PL; Halloran C; Cross AR; Beutler E
    Biochem Biophys Res Commun; 2000 May; 271(3):788-95. PubMed ID: 10814540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human dihydropteridine reductase: a method for the measurement of activity in cultured cells, and its application to malignant hyperphenylalaninemia.
    Firgaira FA; Cotton RG; Danks DM
    Clin Chim Acta; 1979 Jul; 95(1):47-59. PubMed ID: 41656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Tetrahydrobiopterin level and NADH-specific dihydropteridine reductase activity in chick embryo liver during development].
    Matsumoto K; Nakanishi N; Yamada S
    Meikai Daigaku Shigaku Zasshi; 1988; 17(3):345-52. PubMed ID: 3271918
    [No Abstract]   [Full Text] [Related]  

  • 15. Diagnosis of dihydropteridine reductase deficiency by erythrocyte enzyme assay.
    Narisawa K; Arai N; Hayakawa H; Tada K
    Pediatrics; 1981 Oct; 68(4):591-2. PubMed ID: 7322696
    [No Abstract]   [Full Text] [Related]  

  • 16. [Active form of dihydropteridine reductase in human chorion cells. Possibility of prenatal diagnosis].
    Gromov PS; Bakharev VA; Annenkov GA
    Vopr Med Khim; 1985; 31(4):73-5. PubMed ID: 4049790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of antibodies to sheep liver dihydropteridine reductase: characterization and use to study the enzyme defect in a variant form of phenylketonuria.
    Milstien S; Kaufman S
    Biochem Biophys Res Commun; 1975 Sep; 66(2):475-81. PubMed ID: 810143
    [No Abstract]   [Full Text] [Related]  

  • 18. [Studies on NADPH-specific dihydropteridine reductase from Macaca fascicularis liver. II. Effect of inhibitors].
    Nakanisi N; Ozawa K; Yamada S; Irie E; Osaka N; Goto H
    Josai Shika Daigaku Kiyo; 1983; 12(2):179-84. PubMed ID: 6585243
    [No Abstract]   [Full Text] [Related]  

  • 19. Dihydropteridine reductase (DHPR), its cofactors, and its mode of action.
    Armarego WL; Randles D; Waring P
    Med Res Rev; 1984; 4(3):267-321. PubMed ID: 6379341
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of dihydropteridine reductase from human platelets.
    Shen R; Abell CW
    J Neurosci Res; 1981; 6(2):193-201. PubMed ID: 7241620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.